Du J, Chen F, Du C, Zhao W, Chen Z, Ding Z
Cell Death Discov. 2024; 10(1):434.
PMID: 39394181
PMC: 11470136.
DOI: 10.1038/s41420-024-02201-1.
Li J, Jia Z, Dong L, Cao H, Huang Y, Xu H
Biomark Res. 2024; 12(1):111.
PMID: 39334297
PMC: 11437670.
DOI: 10.1186/s40364-024-00653-2.
Maarouf A, Iqbal F, Sanaullah S, Locatelli M, Atanasiu A, Kolbin D
Mol Biol Cell. 2024; 35(11):ar136.
PMID: 39292916
PMC: 11617103.
DOI: 10.1091/mbc.E24-04-0188.
Morozumi R, Shimizu N, Tamura K, Nakamura M, Suzuki A, Ishiniwa H
J Radiat Res. 2024; 65(3):315-322.
PMID: 38648785
PMC: 11115444.
DOI: 10.1093/jrr/rrae012.
Her J, Zheng H, Bunting S
J Clin Invest. 2024; 134(10).
PMID: 38530355
PMC: 11093604.
DOI: 10.1172/JCI167419.
ATR signaling controls the bystander responses of human chondrosarcoma cells by promoting RAD51-dependent DNA repair.
Luong N, Kawamura H, Ikeda H, Roppongi R, Shibata A, Hu J
Int J Radiat Biol. 2024; 100(5):724-735.
PMID: 38442236
PMC: 11060906.
DOI: 10.1080/09553002.2024.2324479.
Selective inhibition of DNA ligase IV provides additional efficacy to the treatment of anaplastic thyroid cancer.
Sriramareddy S, Jamakhani M, Vilanova L, Brossel H, Staumont B, Hamaidia M
Front Oncol. 2024; 14:1323313.
PMID: 38380364
PMC: 10876873.
DOI: 10.3389/fonc.2024.1323313.
SARS-CoV-2 exploits cellular RAD51 to promote viral propagation: implication of RAD51 inhibitor as a potential drug candidate against COVID-19.
Pham T, Huynh T, Choi J, Lee J, Park S, Kim B
J Virol. 2023; 97(12):e0173723.
PMID: 38051260
PMC: 10734463.
DOI: 10.1128/jvi.01737-23.
The impact of DNA double-strand break repair pathways throughout the carbon ion spread-out Bragg peak beam.
Buglewicz D, Buglewicz J, Hirakawa H, Kato T, Liu C, Fang Y
Cancer Sci. 2023; 114(12):4548-4557.
PMID: 37786999
PMC: 10727999.
DOI: 10.1111/cas.15972.
DNA repair pathways in breast cancer: from mechanisms to clinical applications.
Tufail M
Breast Cancer Res Treat. 2023; 200(3):305-321.
PMID: 37289340
DOI: 10.1007/s10549-023-06995-z.
High-efficiency and multilocus targeted integration in CHO cells using CRISPR-mediated donor nicking and DNA repair inhibitors.
Hamaker N, Lee K
Biotechnol Bioeng. 2023; 120(9):2419-2440.
PMID: 37039773
PMC: 10524319.
DOI: 10.1002/bit.28393.
The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistance.
Ovejero S, Viziteu E, Dutrieux L, Devin J, Lin Y, Alaterre E
Front Immunol. 2022; 13:983181.
PMID: 36569948
PMC: 9780552.
DOI: 10.3389/fimmu.2022.983181.
Targeting RAD51-Mediated Homologous Recombination as a Treatment for Advanced Solid and Hematologic Malignancies: Opportunities and Challenges Ahead.
Tsang E, Munster P
Onco Targets Ther. 2022; 15:1509-1518.
PMID: 36536949
PMC: 9758980.
DOI: 10.2147/OTT.S322297.
Heat Shock Protein Family A Member 1 Promotes Intracellular Amplification of Hepatitis B Virus Covalently Closed Circular DNA.
Tang L, An P, Zhao Q, Winkler C, Chang J, Guo J
J Virol. 2022; 97(1):e0126122.
PMID: 36519896
PMC: 9888207.
DOI: 10.1128/jvi.01261-22.
Direct evidence of CRISPR-Cas9-mediated mitochondrial genome editing.
Bi R, Li Y, Xu M, Zheng Q, Zhang D, Li X
Innovation (Camb). 2022; 3(6):100329.
PMID: 36275864
PMC: 9579715.
DOI: 10.1016/j.xinn.2022.100329.
Inhibitors of the Fanconi anaemia pathway as potential antitumour agents for ovarian cancer.
Taylor S, Arends M, Langdon S
Explor Target Antitumor Ther. 2022; 1(1):26-52.
PMID: 36046263
PMC: 9400734.
DOI: 10.37349/etat.2020.00003.
Abrogation of Cellular Senescence Induced by Temozolomide in Glioblastoma Cells: Search for Senolytics.
Beltzig L, Christmann M, Kaina B
Cells. 2022; 11(16).
PMID: 36010664
PMC: 9406955.
DOI: 10.3390/cells11162588.
Targeting Replication Stress Response Pathways to Enhance Genotoxic Chemo- and Radiotherapy.
Nickoloff J
Molecules. 2022; 27(15).
PMID: 35897913
PMC: 9330692.
DOI: 10.3390/molecules27154736.
Recent Advances in the Development of Non-PIKKs Targeting Small Molecule Inhibitors of DNA Double-Strand Break Repair.
Kelm J, Samarbakhsh A, Pillai A, VanderVere-Carozza P, Aruri H, Pandey D
Front Oncol. 2022; 12:850883.
PMID: 35463312
PMC: 9020266.
DOI: 10.3389/fonc.2022.850883.
dCas9-based gene editing for cleavage-free genomic knock-in of long sequences.
Wang C, Qu Y, Cheng J, Hughes N, Zhang Q, Wang M
Nat Cell Biol. 2022; 24(2):268-278.
PMID: 35145221
PMC: 8843813.
DOI: 10.1038/s41556-021-00836-1.